Company: TVRD
Filing Date: 2025-04-01
Form Type: 8-K
Source: 0001104659-25-030583
Chunk: 0

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-04-01
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07      Submission of Matters to a Vote of Security Holders.  

On April 1, 2025, Cara
Therapeutics, Inc. (the “ Company”) held its Special Meeting of Stockholders (the “ Special Meeting”). At the Special
Meeting, the Company’s stockholders voted on the six proposals set forth below.

At the close of business
on February 5, 2025, the record date for the Special Meeting, there were 4,571,229 shares of the Company’s common stock issued and
outstanding. The holders of a total of 2,257,479 shares of the Company’s common stock were represented at the Special Meeting by proxy
or by attendance at the virtual meeting, representing approximately 49.38% of the Company’s issued and outstanding common stock as
of the record date, which total constituted a quorum for the Special Meeting in accordance with the Company’s bylaws.

The final voting results
for each of the proposals voted upon at the Special Meeting is set forth below. For more information on the proposals voted upon at the
meeting, please refer to the Company’s definitive proxy statement for the Special Meeting dated February 14, 2025.

Proposal No. 1 - 
Approval of the Issuance of Shares of the Company’s Common Stock Pursuant to the Merger (defined below)

The stockholders approved
the issuance of shares of the Company’s common stock pursuant to the merger (the “ Merger”) of CT Convergence Merger
Sub, Inc., a wholly owned subsidiary of the Company, with and into Tvardi Therapeutics, Inc. (“ Tvardi”), with Tvardi surviving
the Merger as a wholly owned subsidiary of the Company, which (i) will represent more than 20% of the shares of the Company’s
common stock outstanding immediately prior to the Merger and (ii) result in the change of control of the Company, pursuant to Rules
5635(a) and 5635(b) of Nasdaq, respectively (the “ Stock Issuance Proposal”), by the following votes:

  Votes For      Votes Against      Abstentions      Broker Non-Votes  
 ───────────────────────────────────────────────────────────────────────
  2,088,293            166,062            3,124      —                 

Proposal No. 2 - Approval
of Equity Plan